SLC25A22 and mucopolysaccharidosis type 1: However, although mutations of GC1 leading to a complete loss of function have been reported in patients with EEE or MPSI (Molinari et al., 2005, 2009; Poduri et al., 2013), no study of GC1 inhibition in cerebral cells has been performed hitherto.